ClinicalTrials.Veeva

Menu

EUS-guided Biliary Drainage of First Intent With the Lumen Apposing Metal Stent vs. ERCP in the Management of Malignant Distal Biliary Obstruction (AXIOS-CPRE)

R

Ramsay Générale de Santé

Status

Completed

Conditions

Endoscopic Retrograde Cholangiopancreatography
Echography Ultrasound
Biliary Drainage

Treatments

Procedure: EUS guided biliary drainage
Procedure: ERCP

Study type

Interventional

Funder types

Other

Identifiers

NCT05122858
2020-A00654-35

Details and patient eligibility

About

The main objective is to compare the EUS-BD with the insertion of a LAMS vs. traditional ERCP to restore biliary patency. Although ERCP has been the primary treatment for many years, it is associated with a significant risk of procedural complications and possible stent blockage. EUS-BD has been shown to be potentially safer and is associated with a lower risk of stent blockage. We seek with our study to determine whether EUS-BD may be the most effective treatment modality.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Radiological diagnosis (with or without pathological diagnosis) of a malignant obstruction of the borderline resectable distal bile ducts, locally advanced or unresectable distal to the hilum, at a minimum distance of 2 cm.
  • Resectability based on tumor staging after axial imaging and evaluation by a physician (surgeon, oncologist and / or gastroenterologist).
  • High results of the liver function test with a serum bilirubin level at least 3 times above the upper limit of normal (18.9 μmol / L)
  • Dilated extrahepatic bile duct measuring at least 1.2 cm in axial imaging, ultrasound or endoscopy.
  • Karnofsky index> 30%
  • ASA score <IV
  • Patient accepting the constraints of research
  • Patient affiliated or beneficiary of a social security scheme
  • Patient having signed an informed consent

Exclusion criteria

    • Hilar obstruction (biliary obstruction located <2 cm from the hilum)
  • Coagulopathy and / or thrombocytopenia that cannot be corrected
  • Age <18 years old
  • Liver metastases involving> 30% of hepatic volume
  • Liver cirrhosis with portal hypertension or ascites
  • Biliary sphincterotomy or placement of a stent performed in the past
  • Anatomy modified by surgery
  • Common bile ducts measuring less than 1.2 cm will be excluded.
  • Patient with clinical and radiological signs of stenosis of the gastric outlet
  • Patient participating in another clinical study
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant, breastfeeding or parturient woman
  • Patient hospitalized without consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

15 participants in 2 patient groups

EUS guided biliary drainage
Experimental group
Treatment:
Procedure: EUS guided biliary drainage
ERCP (Endoscopic Retrograde Cholangiopancreatography
Active Comparator group
Treatment:
Procedure: ERCP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems